GAPP Urges U.S. to Support a Fully Funded Global Fund
Investment Case Shows Global Fund’s Impact in Fighting Duel Pandemics of COVID and HIV/AIDS
In the release of its Investment Case today, the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) projects the total cost for fighting three of the world’s deadliest diseases at $130.2 billion over the next three years; of that, the multilateral organization needs $18 billion to continue its critical role in the response. The Global AIDS Policy Partnership (GAPP) urges the United States, the largest donor to the Global Fund, to continue its generous support by recommitting to robust funding at the upcoming Replenishment later this year.
The Global Fund has been instrumental in the global fight against HIV/AIDS, helping to:
- Save 44 million lives;
- Decrease AIDS-related deaths by 68% since the peak of the epidemic in 2004 in countries where it invests; and
- Provide 21.9 million people living with HIV with lifesaving antiretroviral therapy.
However, the COVID-19 pandemic threatens to reverse these extraordinary gains. For the first time in the history of the Global Fund, key prevention and testing services declined in 2020 compared to the previous year.
Without vital investments in the Global Fund and its bilateral partners including the President’s Emergency Plan for AIDS Relief (PEPFAR), we will not reach the global health targets set out at the United Nations General Assembly High-Level Meeting on AIDS in June 2021. This will set the world far off track, resulting in:
- 1,785,000 more HIV infections;
- 753,000 additional AIDS deaths by 2025;
- And 1,531,070 people without life-saving treatment.
The U.S. has been a generous supporter of the Global Fund since its founding and is its largest donor to date, having contributed a total of US $17 billion. It has also shown unwavering leadership with a commitment to hosting this year’s seventh Replenishment conference in November. Though COVID-19 and waning investments globally have put progress and hard-won gains at risk, with strategic investments from the U.S. and partner countries, the Global Fund and PEPFAR, together, can leverage past investments; expand successful programming; and spur innovation to end HIV as a public health threat by 2030.